NOTICES 
33577 
RECOMBINANT DNA MOLECULE 
PROGRAM ADVISORY COMMITTEE 
Meeting 
Pursuant to Pub. L. 92-463, notice is 
hereby given of the meeting of the 
Recombinant DNA Molecule Program 
Advisory Committee on September 13- 
14, 1976, 9 a.m., at the National Institutes 
of Health, Building 1, Wilson Hall, Be- 
thesda, Maryland. This meeting will be 
open to the public on September 13, from 
9 a.m. to 5 p.m., and September 14, from 
9 a.m. to 3 p.m. to discuss: guidelines 
for reseal ch involving recombinant DNA 
molecules, the status of research in the 
field, research studies required, the 
mechanisms by which such studies should 
be supported, and the identification of 
facilities and resources needed in their 
performance. Attendance by the public 
will be limited to space available. 
In her ordance with the provisions 
set forth in sections 552(b)(4), 552(b) 
(5) and 552(b)(6), Title 5, U.S. Code 
and section 10(d) of Pub. L. 92-463, the 
meeting will be closed to the public on 
September 14 from 3 p.m. to 5 p.m. for 
the review, discussion and evaluation of 
initial pending and renewal grant appli- 
cations. The closed portion of the meet- 
ing involves solely the internal expression 
of views and judgments of committee 
members on individual grant applications 
containing . detailed research protocols, 
designs, and other technical informa- 
tion: financial data, such as salaries: and 
personal information concerning individ- 
uals associated with the applications. 
Dr. W.lliam J. Gartland, Executive 
Secret?^, National Institutes of Health, 
Building 31, Room 4A52, Bethe.sda. Mary- 
land 20014, telephone (301) 496-2323, 
will provide summaries of the meeting, 
rosters of committee members and sub- 
stantive program information. 
Dated: August 2, 1976. 
R. W. Lamont-Havers, 
Deputy Director, 
National Institutes of Health. 
[FR Dot .76-23185 Filed 8-9-76:8:45 am] 
FEDERAL REGISTER, VOL 41, NO. 155— TUESDAY, AUGUST 10, lt/0 
[ 576 ] 
